(Press-News.org) PULLMAN, Wash. —Short science-backed messages about the health risks of using cannabis while pregnant could be an effective way to discourage the dangerous trend.
In a new study published in Psychology of Addictive Behaviors, researchers at Washington State University found that conveying simple, scientific facts about how THC can harm a fetus was associated with reduced intentions to use cannabis while pregnant. This held true for messaging that was written to a group of women, aged 18-40, in either a narrative, story-based format or a non-narrative, factual-based one.
Additionally, the researchers found that short and simple communications designed to increase media literacy, or the ability to discern factual sources of information from non-factual ones, also reduced intentions to use cannabis while pregnant.
As cannabis use continues to gain popularity across the country, the research could help provide effective guidelines on how to communicate to pregnant people about the adverse consequences of using the drug.
“While some messaging around the risks of using cannabis while pregnant exist, as far as we know, there hasn’t been a systematic evaluation of those messages or tests for what types of messages can be most effective,” said Jessica Willoughby, lead author of the study and an associate professor of communication at WSU. “This is becoming a big issue as cannabis use continues to gain popularity and there is an ever-increasing amount of misinformation out there about the drug.”
Cannabis use during pregnancy has been largely understudied, but existing research suggests there are detrimental effects in newborns such as lower birth weight, higher rates of admission to neonatal intensive care units and an increased risk of stillbirth.
Despite this, a startling 70% of pregnant and non-pregnant women believe there is slight to no risk of harm from using cannabis once or twice a week while pregnant, according to a 2015 study.
Prior research conducted by study coauthor and Professor Celestina Barbosa-Leiker of the WSU College of Nursing reveals that many of these women are getting their information about the health risks of using cannabis while pregnant from budtenders and other non-expert sources.
In this work, she asked pregnant and postpartum women about their experiences using cannabis for health-related reasons and they noted that their healthcare providers often lacked knowledge on the impacts of their cannabis use on their baby or gave mixed messages on possible consequences of cannabis use.
For the current study, the WSU researchers designed scientific and media literacy messaging in narrative and non-narrative formats. The narrative formats took bits of information from people’s real-life stories to craft messaging that would resonate with the intended audience. The non-narrative messaging simply conveyed facts, such as THC, the substance that makes you feel high, can also cross the placenta and reach your baby. Giving up marijuana while pregnant can keep THC away from your developing baby.
“We had to be so thoughtful in order not to stigmatize the use of cannabis or particular populations that use cannabis when we were designing the messaging for this study,” said Stacey Hust, study coauthor and a WSU professor of communication. “We even surveyed pregnant people on variables, such as the color scheme and whether or not to include the faces of people we were displaying.”
The researchers then surveyed some 429 women about how the different forms of messaging impacted their decisions to use cannabis. The results of the analysis indicated that straight-forward, non-narrative messages that focused on scientific facts about cannabis use during pregnancy were the most effective solution. While the narrative messages were also effective in the science communication category, the researchers did not find them effective when trying to educate people about media literacy.
“The ambiguity of the more complex messaging may overly complicate things and make it less effective, especially on social media,” Willoughby said. “In fact, our results indicate short Instagram stories can be used to convey factual information but may not provide enough space to discuss complex storylines.”
Moving forward, Willoughby, Hust and Barbosa-Leiker said their hope is that the research will ultimately be used to communicate facts about cannabis use during pregnancy in doctor’s offices, cannabis shops and schools.
“I think we could target medical providers, bud tenders and cannabis stores with this type of messaging to help reach people,” Hust said. “But to be honest, I think this information needs to be provided way before someone can legally use cannabis. We should probably be talking to young women in high school when we are talking to them about reproductive issues and how babies are made.”
END
Science-focused messaging could help reduce cannabis use during pregnancy
2023-05-16
ELSE PRESS RELEASES FROM THIS DATE:
Nemours Children’s Health to host first gene therapy clinical trial for Morquio A syndrome
2023-05-16
WILMINGTON, Del. (May 16, 2023) – As part of the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP® BGTC), Nemours Children’s Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.
Nemours Children’s will work collaboratively with the FNIH AMP® BGTC, a public-private partnership between the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), biopharmaceutical and life science companies, and non-profit ...
Worldwide Emergency Medical Services receive the Ethica Award at EuroPCR 2023
2023-05-16
EMBARGO: 16 May 2023 at 08:00 CEST
Paris, France. At EuroPCR 2023, the interventional community paid tribute to Emergency Medical Services throughout the world for their critical role in enabling timely care. International representatives of emergency medical services received the Andreas Grüntzig Ethica Award at the opening ceremony of this year’s Course, further spotlighting the importance of their work in the establishment of networks for the care of STEMI patients.
This year, EuroPCR 2023 celebrated 30 years of primary percutaneous coronary ...
René Medema new CSO at Princess Máxima Center
2023-05-16
Prof. dr. René Medema has an excellent scientific track record. He leads a prominent research group and has an extensive national and international network. He also has more than ten years of executive experience in a position with final responsibility as chairman of the board of the Antoni van Leeuwenhoek. Medema is very motivated to fulfill the administrative role in the Princess Máxima Center, he says. ‘It’s great to make a substantial contribution to further improving the prospects for ...
Chemists unravel reaction mechanism for clean energy catalyst
2023-05-16
UPTON, NY—Hydrogen, the simplest element on Earth, is a clean fuel that could revolutionize the energy industry. Accessing hydrogen, however, is not a simple or clean process at all. Pure hydrogen is extremely rare in nature, and practical methods to produce it currently rely on fossil fuels. But if scientists find the right chemical catalyst, one that can split the hydrogen and oxygen in water molecules apart, pure hydrogen could be produced from renewable energy sources such as solar power.
Now, ...
Effects of zoledronic acid on senescence and SASP markers
2023-05-16
“In the present study, we used multiple complementary approaches to evaluate the possible effects of zoledronic acid on cellular senescence.”
BUFFALO, NY- May 15, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers.”
Zoledronic acid has been found to reduce fracture ...
Automated agricultural machinery requires new approaches to ensuring safety
2023-05-16
URBANA, Ill. — From self-driving tractors to weeding robots and AI-powered data collection, automated machinery is revolutionizing agricultural production. While these technological advancements can greatly improve productivity, they also raise new questions about safety measures and regulations. To address these issues, a recent study from the University of Illinois reviewed current academic literature on the safety of automated agricultural machines. Based on a review of more than 60 papers, the researchers identified three ...
Experts say it’s not yet time to take off masks in the health care setting
2023-05-16
1. Experts say it’s not yet time to take off masks in the health care setting
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1190
URL goes live when the embargo lifts
A new commentary from infectious disease experts at George Washington University School of Medicine and the National Institutes of Health (NIH) says for patient safety, masking should continue in health care settings. This message conflicts with a recent commentary from authors from 8 U.S. institutions suggesting that the time for universal masking is over. The commentary is published in Annals of Internal Medicine.
Masking has been a controversial ...
The number of the world's farms to halve by 2100, study shows
2023-05-16
New University of Colorado Boulder research shows the number of farms globally will shrink in half as the size of the average existing farms doubles by the end of the 21st century, posing significant risks to the world’s food systems.
Published today in the journal Nature Sustainability, the study is the first to track the number and size of farms year-over-year, from the 1960s and projecting through 2100.
The study shows that even rural, farm-dependent communities in Africa and Asia will experience a drop in the number of operating farms.
“We see a turning point from widespread farm creation to widespread consolidation on a global level, and that's ...
Investigation raises questions over lack of “substantial evidence” for FDA approved antibiotic
2023-05-16
Drugs approved in the US require “substantial evidence” that they are effective. But an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
Peter Doshi, senior editor at The BMJ, describes how US Food and Drug Administration (FDA) scientists had serious doubts about Recarbrio - a product 40 times more expensive than an existing generic alternative - but the agency approved it anyway.
Did the FDA break its own rules in approving this antibiotic, and what does this case tell us about problems within the agency, he asks?
Recarbrio is a combination therapy made up ...
Chemical exposure may raise your risk for Parkinson’s
2023-05-16
Two years of heavy exposure to TCE, a liquid chemical that lingers in the air, water and soil, may increase the risk of Parkinson’s disease by 70%.
Previous research has linked TCE, or trichloroethylene, to certain cancers, but a new study publishing in JAMA Neurology on May 15, 2023, is believed to be the first large-scale study to demonstrate its association with Parkinson’s.
TCE has been used for industrial and commercial purposes for nearly 100 years, and was used ...